A Study of LY3537982 in Chinese Participants With Advanced Solid Tumors

NCT06235983 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: LY3537982

Sponsor

Eli Lilly and Company